SWATH-MS for prospective identification of protein blood biomarkers of rtPA-associated intracranial hemorrhage in acute ischemic stroke: a pilot study
Abstract Intravenous recombinant tissue plasminogen activator (rtPA) is, besides mechanical thrombectomy, the highest class evidence based reperfusion treatment of acute ischemic stroke (AIS). The biggest concern of the therapy is symptomatic intracranial hemorrhage (sICH), which occurs in 3–7% of a...
Guardado en:
Autores principales: | Bartosz Karaszewski, Anna Gójska-Grymajło, Paulina Czaplewska, Bartosz Jabłoński, Aleksandra E. Lewandowska, Daria Ossowska, Adam Wyszomirski, Marek Hałas, Edyta Szurowska |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96896a15699e4a57b8dea914c34db695 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Prostate Cancer Proteomics Database for SWATH-MS Based Protein Quantification
por: Ammara Muazzam, et al.
Publicado: (2021) -
Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke
por: Cyrille Orset, et al.
Publicado: (2021) -
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells
por: Gina L. Eagle, et al.
Publicado: (2021) -
Generation of a mouse SWATH-MS spectral library to quantify 10148 proteins involved in cell reprogramming
por: Uxue Ulanga, et al.
Publicado: (2021) -
Corneal proteome and differentially expressed corneal proteins in highly myopic chicks using a label-free SWATH-MS quantification approach
por: Byung Soo Kang, et al.
Publicado: (2021)